Correlation Between Instil Bio and Hepion Pharmaceuticals

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Instil Bio and Hepion Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Instil Bio and Hepion Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Instil Bio and Hepion Pharmaceuticals, you can compare the effects of market volatilities on Instil Bio and Hepion Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Instil Bio with a short position of Hepion Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Instil Bio and Hepion Pharmaceuticals.

Diversification Opportunities for Instil Bio and Hepion Pharmaceuticals

-0.26
  Correlation Coefficient

Very good diversification

The 3 months correlation between Instil and Hepion is -0.26. Overlapping area represents the amount of risk that can be diversified away by holding Instil Bio and Hepion Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Hepion Pharmaceuticals and Instil Bio is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Instil Bio are associated (or correlated) with Hepion Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Hepion Pharmaceuticals has no effect on the direction of Instil Bio i.e., Instil Bio and Hepion Pharmaceuticals go up and down completely randomly.

Pair Corralation between Instil Bio and Hepion Pharmaceuticals

Considering the 90-day investment horizon Instil Bio is expected to under-perform the Hepion Pharmaceuticals. In addition to that, Instil Bio is 2.48 times more volatile than Hepion Pharmaceuticals. It trades about -0.05 of its total potential returns per unit of risk. Hepion Pharmaceuticals is currently generating about -0.01 per unit of volatility. If you would invest  65.00  in Hepion Pharmaceuticals on August 30, 2024 and sell it today you would lose (1.00) from holding Hepion Pharmaceuticals or give up 1.54% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Instil Bio  vs.  Hepion Pharmaceuticals

 Performance 
       Timeline  
Instil Bio 

Risk-Adjusted Performance

10 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Instil Bio are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. Despite quite weak forward indicators, Instil Bio disclosed solid returns over the last few months and may actually be approaching a breakup point.
Hepion Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Hepion Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors.

Instil Bio and Hepion Pharmaceuticals Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Instil Bio and Hepion Pharmaceuticals

The main advantage of trading using opposite Instil Bio and Hepion Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Instil Bio position performs unexpectedly, Hepion Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Hepion Pharmaceuticals will offset losses from the drop in Hepion Pharmaceuticals' long position.
The idea behind Instil Bio and Hepion Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.

Other Complementary Tools

Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Equity Valuation
Check real value of public entities based on technical and fundamental data
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes